It is what happens when you keep returning to the exact same spot
Aetna Medicare Advantage plans begin covering GLP-1 medications for weight loss in July 2026 under a new CMS rule
There appears to be great promise for this entire class of GLP1-RA [GLP-1 receptor agonist] drugs, and semaglutides in particular
Campone M, Berton-Rigaud D, Joly-Lobbedez F, et al
Benefits Tesamorelin + Ipamorelin is believed to help with: Targeted visceral fat reduction: Tesamorelin has been shown to reduce VAT area and improve VAT quality and lipid profiles while sparing subcutaneous fat, supporting both health and aesthetics. Lean mass and recovery support: Ipamorelin selectively boosts GH/IGF1 to promote protein synthesis, lean mass, strength, and exercise recovery with a favorable sideeffect profile compared with many GH secretagogues. Improved recomposition and performance: Stacking the two can yield better waistlines, tighter midsections, stronger training sessions, and more resilient recovery than either alone when combined with strength training and adequate protein. Labguided, cyclical use: Protocols often run 8-12 weeks with 5dayson/2daysoff injections, periodic breaks, and monitoring of IGF1, glucose, and lipids to align benefits with safety.
It was suspected that the latter may be driven by changes in body composition and psychology caused by the weight loss [41]
